Cargando…
PS212. Effects of Proton Pump Inhibitors (PPI) on the Serum Concentrations of Venlafaxine
Autores principales: | Paulzen, Michael, Gründer, Gerhard, Haen, Ekkehard, Kuzin, Maxim, Lammertz, Sarah E., Schoretsanitis, Georg, Stegmann, Benedikt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616807/ http://dx.doi.org/10.1093/ijnp/pyw043.212 |
Ejemplares similares
-
PT705. Therapeutic Drug Monitoring (TDM) in maternal serum, amniotic fluid and umbilical cord blood during pregnancy and delivery
por: Paulzen, Michael, et al.
Publicado: (2016) -
Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia
por: Gaebler, Arnim Johannes, et al.
Publicado: (2023) -
Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
por: Kenngott, S, et al.
Publicado: (2010) -
Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct Disorders
por: Piacentino, Daria, et al.
Publicado: (2020) -
The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?
por: Sharma, Rakesh K, et al.
Publicado: (2010)